[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The Lithium "Lie"]( [Find Out How Investors Can Benefit From the Energy War with China]( --------------------------------------------------------------- February 07, 2023 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Elon Mush Claims Solar Will Soon Power the World]( world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market. [See Why This is Such a Huge Untapped Market Opportunity]( --------------------------------------------------------------- [Cytosorbents, CTSO]( Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on [Cytosorbents (CTSO)](in the Healthcare sector with a Buy rating and a price target of $16.00 (2 months ago). - Recent Price: $$4.12 - Average Analyst Price Target: $16.00 (288.35%) - Market Cap: $$155.34M [TipRanks.com]( also reports that [Cytosorbents](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.00 . The target pricing ranges from a high forecast of $16.00 down to a low forecast of $16.00. [Cytosorbents (CTSO)](’s last closing price was $$4.12 which would put the average price target at $$16.00. Here are 3rd party ratings for [CTSO](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Sell every Stock except ONE]( are down... But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month... [Ticker Revealed.]( --------------------------------------------------------------- [Arqit Quantum, ARQQ]( Recent Analyst Action: Jamie Shelton, analyst at Deutsche Bank, reiterates coverage on [Arqit Quantum (ARQQ)](in the Technology sector with a Hold rating and a price target of $3.50 (3 weeks ago). - Recent Price: $$2.84 - Average Analyst Price Target: $8.75 (208.10%) - Market Cap: $$306.69M [TipRanks.com]( also reports that [Arqit Quantum](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.75 . The target pricing ranges from a high forecast of $14.00 down to a low forecast of $3.50. [Arqit Quantum (ARQQ)](’s last closing price was $$2.84 which would put the average price target at $$8.75. Here are 3rd party ratings for [ARQQ](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 42% (105 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Velo3D, VLD]( Recent Analyst Action: James Ricchiuti, analyst at Needham, reiterates coverage on [Velo3D (VLD)](in the Industrial Goods sector with a Buy rating and a price target of $4.00 (2 months ago). - Recent Price: $$3.18 - Average Analyst Price Target: $4.00 (25.79%) - Market Cap: $$549.94M [TipRanks.com]( also reports that [Velo3D](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4.30 down to a low forecast of $3.70. [Velo3D (VLD)](’s last closing price was $$3.18 which would put the average price target at $$4.00. Here are 3rd party ratings for [VLD](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 21% (52 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The No. 1 Threat to the U.S. Economy Right Now]( ��s not a recession, inflation or stock market crash — according to one expert: “Those are the least of our worries.” There’s a looming event that he believes will be far worse. This event will ignite a crisis more dangerous than anything America has seen since the Great Depression. Yet no one is talking about it. In [this shocking new exposé](, you will discover everything you need to know to sidestep the calamity. And perhaps even profit from it. To watch it, free of charge, [click here now.]( --------------------------------------------------------------- [89bio, ETNB]( Recent Analyst Action: Ed Arce, analyst at H.C. Wainwright, reiterates coverage on [89bio (ETNB)](in the Healthcare sector with a Buy rating and a price target of $27.00 (10 hours ago). - Recent Price: $$14.48 - Average Analyst Price Target: $25.80 (78.18%) - Market Cap: $$616.15M [TipRanks.com]( also reports that [89bio](currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $25.80 . The target pricing ranges from a high forecast of $34.00 down to a low forecast of $17.00. [89bio (ETNB)](’s last closing price was $$14.48 which would put the average price target at $$25.80. Here are 3rd party ratings for [ETNB](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 37% (92 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Akoustis Technologies, AKTS]( Recent Analyst Action: Craig Ellis, analyst at B.Riley Financial, reiterates coverage on [Akoustis Technologies (AKTS)](in the Technology sector with a Buy rating and a price target of $9.25 (2 weeks ago). - Recent Price: $$4.56 - Average Analyst Price Target: $7.06 (54.82%) - Market Cap: $$302.05M [TipRanks.com]( also reports that [Akoustis Technologies](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.06 . The target pricing ranges from a high forecast of $9.25 down to a low forecast of $5.00. [Akoustis Technologies (AKTS)](’s last closing price was $$4.56 which would put the average price target at $$7.06. Here are 3rd party ratings for [AKTS](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Bottom 11% (222 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Mover Over Lithium - 220 Pounds of Graphite In Every EV Battery]( constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska. [See Why Investors Are So Excited About This New Mineral Claim Discovery]( --------------------------------------------------------------- [Poseida Therapeutics, PSTX]( Recent Analyst Action: Jennifer Kim, analyst at Cantor Fitzgerald, reiterates coverage on [Poseida Therapeutics (PSTX)](in the Healthcare sector with a Buy rating and a price target of $24.00 (6 days ago). - Recent Price: $$8.32 - Average Analyst Price Target: $17.67 (112.38%) - Market Cap: $$690.17M [TipRanks.com]( also reports that [Poseida Therapeutics](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $17.67 . The target pricing ranges from a high forecast of $24.00 down to a low forecast of $14.00. [Poseida Therapeutics (PSTX)](’s last closing price was $$8.32 which would put the average price target at $$17.67. Here are 3rd party ratings for [PSTX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 37% (92 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Unity Biotechnology, UBX]( Recent Analyst Action: Salim Syed, analyst at Mizuho Securities, reiterates coverage on [Unity Biotechnology (UBX)](in the Healthcare sector with a Buy rating and a price target of $12.00 (2 months ago). - Recent Price: $$5.5 - Average Analyst Price Target: $19.00 (245.45%) - Market Cap: $$70.39M [TipRanks.com]( also reports that [Unity Biotechnology](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.00 . The target pricing ranges from a high forecast of $35.00 down to a low forecast of $10.00. [Unity Biotechnology (UBX)](’s last closing price was $$5.5 which would put the average price target at $$19.00. Here are 3rd party ratings for [UBX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 37% (92 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Profit From the Commercial Solar Boom?]( energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. [See What's Going on With the Solar Industry in This Special Investor's Report]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software